Ann: Market Update - Executing Towards Profitability in Oncology, page-111

Would you mind explaining what you mean by SOZO being useful in only one or two stages of the cycle (of a dialysis patient)?

Thr figures I gave come from a couple of discussions with our former IR man . Medicare pays about USD250 per dialysis treatment, end private payors much more. To think that the dialysis centres could not spare $1 - or even $2 - per session if it were proved that more accurate removal of fluid buildup helped prevent problems like sudden death from cardiac arrest due to imbalances in electrolytes!
(a common cause of death of renal patients)
This would give the USD1-2000 per month licence fee.(Yes, I know not as good as lymphedema, but at least in the same ballpark)
I suppose I should avoid a defamatory statement, but I am suspicious of RV after what he said about Tandem Diabetes. Did he say directly to you that the dialysis centres would pay only $3-400 per month?
Again defamatory - I wonder whether he decided that he didn't want to take the trouble of starting on renal - even an initial scoping - so he plucked unfavourable figures out of the air.
At any rate,@Megamao , would you please respond to those two questions.
Thanks, Mirri